Rogier Mous, MD

UMC Utrecht Cancer Center, Netherlands

N/A

Poster(s):

• 1441 - A functional prognostic model predicts progression free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax